Navigation Links
HPS Establishes Independent Website for its Patent-Pending Mood-Enhancing Compound Naturally Found in Sea Coral
Date:1/21/2009

SAN JOSE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") announced that it has established a website devoted to its newly-announced mood- enhancing compound, ER 303, for which the Company filed Comprehensive Patent Applications with both the U.S. Patent and Trademark Office and the International Bureau of the World Patent Office. On the site, the Company released additional data regarding the testing that was performed on male and female volunteers, which show significant improvement in several aspects of mood enhancement.

"We felt it appropriate to develop this website to respond to requests received about this innovative and previously undeveloped compound, with its origin in sea coral, which has significant emotional impacts on both men and women, enhancing feelings of positive social relationships, personal well- being and social attraction", a Company spokesperson noted. "Hopefully, the data contained on this site will answer initial questions that have been posed since the Company's original announcement", the spokesperson indicated.

In addition to the Company's earlier disclosure, the data included on http://www.ER303.com details the definitive results of the testing that was performed, and confirms that prior to the Company's reproduction of this naturally-occurring compound, it could only be found in coral reefs off the coasts of Newfoundland and in the waters off Brazil's Guiabinha Island.

The Company has previously been granted broad-based worldwide patents for its initial compound, Androstadienone, which has been licensed to leading marketers, including Johnson & Johnson, Avon and Schwarkopf and Henkel and its affiliates.

This news release may contain forward-looking statements that involve risks and uncertainties that could cause result
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
2. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
3. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
4. Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
5. Halleland Health Consulting Establishes URAC Accreditation Program
6. Jenny Craig Establishes License Agreement for Volumetrics(R)
7. Disabled Veteran Establishes Non-Profit, AVHRT, to House Injured Veterans
8. Sonic Innovations Establishes Donation Fund for the Armed Forces Foundation
9. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
10. AmeriCares Establishes Field Hospital in China
11. InterComponentWare Establishes ICW Labs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ORK, Nov. 30 Reportlinker.com anno...le in its catalogue: ,, The Future of Senior N...rgeted opportunities for older consumers ,, h...Senior-Nutrition-Key-ingredients-strategic-issues-...l ,, Seniors, have emerged as a powerful consu...
(Date:11/30/2009)...ER SPRING, Md., Nov. 30 ...nzed body year-round, but the ultraviolet (UV) rad...ks. ,, (Logo: http://www.newscom.com/cgi-bin/...le think that a tan gives them a ,healthy, glow, a...er, M.S.E.E., a Food and Drug Administration (FDA)...
(Date:11/30/2009)..., N.J., Nov. 30 Advanced Health Me...ng logistics, speaker programs and commercial comp...ndustry, announced it has been named the second fa...ersey,s leading statewide business newspaper. AHM...at have made significant contributions to the stat...
(Date:11/30/2009)...ation of Urology (EAU) and Europa Uomo, the Europe...te cancer, have entered into an,affiliated partne...rease and improve,patient awareness in Europe wit...-Anders Abrahamsson, Secretary-General of the EAU:...p, Europa Uomo will gain access to the latest info...
(Date:11/30/2009)... to inhibit their response to a "cocaine-cues" vid...to suppress activity in brain regions linked to dr...epartment of Energy,s Brookhaven National Laborato...sue of NeuroImage , suggest that clinical interve...ponses could help cocaine abusers stop using drugs...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 2Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 3Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 4Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 5Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 6Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 7Health News:Reportlinker Adds The Future of Senior Nutrition: Key Ingredients, Strategic Issues and Targeted Opportunities for Older Consumers 8Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3
... Associates, LLC announced today that it has issue...on Authentidate Holding Corp. (ADAT: Nasdaq). The ....com . , , Authentidate Holding Corp. ("Authentid...oftware and web-based services enable healthcare o...
...wire-Asia-FirstCall/ -- China Shenghuo,Pharmaceuti...a Shenghuo" or,the "Company"), today announced the... align with the Company,s business outlook, to opt...paration for the anticipated,growth in its sales a...
...tes Ability to Treat Subcutaneous Infections , , ...ls, Inc. (NYSE Alternext: NBY), a clinical stage b... preclinical data related to NVC-422, the lead mol... San Francisco during March 6-10, 2009. NovaBay i...
...t, sensing systems that will help the UK,s 700,000...ld be available commercially. , Once installed, t...s movements and actions around the home. As well a...inate potential dangers. , Developed at the Unive...
...ocial Work Month highlights purpose-driven careers... (Vocus) March 4, 2009 -- C...or both personal satisfaction and professional gro...lsup , a national Social Security Disability Insur...
...rvical cancer may direct more women to optimal the...erm morbidity and complications of trimodality the...ng to a study performed at the Institute for Techn...ent imaging with MRI and/or PET/CT in patients wit...
Other Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp. 3Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 2Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 3Health News:China Shenghuo Announces Management Expansion and Enhanced Internal Controls 4Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 3Health News:New 'smart' homes for dementia sufferers 2Health News:Employment for Social Workers To Grow Significantly By 2016 2Health News:Employment for Social Workers To Grow Significantly By 2016 3Health News:MRI and PET/CT improve cervical cancer patient's chances for optimal treatment 2
(Date:11/30/2009)... BEIJING, Nov. 30 /PRNewswire-Asia-FirstCall/ -- L...US) ("Lotus" or the "Company") a growing developer...ational seller of pharmaceutical,products in the P...that its,Over-the-Counter Drug division ("OTC Divi...with more than five hundred drug stores in Beijing...
(Date:11/30/2009)...YORK, Nov. 30 Stemline Therapeutic...l company and leading developer of oncology compou... that The University of Texas M.D. Anderson Cancer...to a research collaboration. As part of this colla...e I/II clinical trial of SL-401 in patients with a...
(Date:11/30/2009)... , ATLANTA, Georgia, November 3...Support (CDS), an internet-based curriculum for di...hip by MC Strategies/Elsevier and the, University ...unced today that,its second Disability Intensive C...or administrators and learners to use as part of t...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 3Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 1Electronic Health Records Help Cardiac Patients Remain Healthy 53938 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 4Novavax Reports Second Quarter 2009 Financial Results 13450 1Novavax Reports Second Quarter 2009 Financial Results 13450 2Novavax Reports Second Quarter 2009 Financial Results 13450 3Novavax Reports Second Quarter 2009 Financial Results 13450 4Novavax Reports Second Quarter 2009 Financial Results 13450 5Novavax Reports Second Quarter 2009 Financial Results 13450 6Novavax Reports Second Quarter 2009 Financial Results 13450 7Novavax Reports Second Quarter 2009 Financial Results 13450 8Novavax Reports Second Quarter 2009 Financial Results 13450 9EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 1EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 2
...ion on Receptor Associated Protein (RAP), Support...OVATO, Calif., Nov. 6 Raptor Pharmaceuticals,Corp... RPTP), today,announced updates on its preclinical...erived from the human receptor-associated protein ... collaborative research agreement,with the Brigham...
...Its Kind, PASADENA, Calif., Nov. 4 Proactive mea...of 37.2 percent -- and as much as 50,percent -- am...by Kaiser,Permanente Southern California. The stud...l of Bone & Joint Surgery, a peer-reviewed journal...tudy tracked more than,625,000 male and female pat...
Other Medicine Technology:Raptor Pharmaceuticals Provides Update on Targeting Platforms 2Raptor Pharmaceuticals Provides Update on Targeting Platforms 3Raptor Pharmaceuticals Provides Update on Targeting Platforms 4Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 2Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 3Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 4
New Image Cut-to-Fit Convex Flextend Skin Barrier
CenterPointLock Urostomy Pouch
CenterPointLock Stoma Cap
CenterPointLock Sterile Drainable Kits
Medicine Products: